Delivery of bevacizumab by intracranial injection: assessment in glioma model

BACKGROUND: Many reports have indicated that the intravenous administration of bevacizumab produces a number of systemic side effects. Therefore, we investigated the therapeutic effects of intratumoral bevacizumab administration using a glioma animal model. METHODS: The glioma cell lines U251 and U8...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Xiao, Liu, Wen-Jia, Zhang, Hui-Ru, Zhang, Zhi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951223/
https://www.ncbi.nlm.nih.gov/pubmed/29780259
http://dx.doi.org/10.2147/OTT.S159913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951223/
https://www.ncbi.nlm.nih.gov/pubmed/29780259
http://dx.doi.org/10.2147/OTT.S159913

Ejemplares similares